IP Library Granted Patent US 12,270,060
Granted Patent B2
US 12,270,060 · App. 17/606,123 · Granted Apr 8, 2025

Production method for L-cyclic amino acids

Inventors: Masaharu Mizutani (Hyogo, JP); Ryoma Miyake (Tokyo, JP); Hiroshi Kawabata (Tokyo, JP)
Assignee: UBE CORPORATION
C12P13/04C12N9/1096C12N15/70C12P41/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,270,060
App. No.
17/606,123
Granted
Apr 8, 2025
Kind
B2
Abstract

An object of the present invention is to provide a method of industrially producing a high-purity L-cyclic amino acid more inexpensively and with a high efficiency, from a cyclic amino acid having a double bond at the 1-position. The present invention provides a method in which an L-cyclic amino acid is produced by allowing a cyclic amino acid having a double bond at the 1-position to react with a specific enzyme having a catalytic ability to reduce a cyclic amino acid having a double bond at the 1-position to produce an L-cyclic amino acid.

Claims (25)

1. A method of producing an L-cyclic amino acid, the method comprising bringing a cyclic amino acid having a double bond at the 1-position and having the following general formula (I):

wherein A is an alkylene chain which has a chain length of from 1 to 4 atoms, which contains or does not contain at least one hetero atom selected from the group consisting of a sulfur atom, an oxygen atom and a nitrogen atom, in the chain or at the end of the chain, and which has or does not have a substituent,

into contact with a polypeptide shown in (A), (B) or (C) below, a microorganism or cell having the ability to produce said polypeptide or comprising said polypeptide, a processed product of the microorganism or the cell, and/or a culture liquid obtained by culturing the microorganism or the cell and comprising said polypeptide, to produce an L-cyclic amino acid having the following general formula (II):

wherein A is the same as defined above:

(A) a polypeptide comprising the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, 10 or 12;

(B) a polypeptide which comprises the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, 10 or 12 except that 1 to 10 amino acids are deleted, conservatively substituted and/or added, and which has the ability to catalyze the reaction of the following formula (1) to produce the L-cyclic amino acid:

wherein A is the same as defined above;

or

(C) a polypeptide which comprises an amino acid sequence having a sequence identity of 95% or more to the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, 10 or 12, and which has the ability to catalyze the reaction of the formula (1) to produce the L-cyclic amino acid.

2. The method of producing an L-cyclic amino acid according to claim 1 , wherein the polypeptide is encoded by a nucleic acid shown in (D) or (E) below:

(D) a nucleic acid comprising the nucleotide sequence of SEQ ID NO: 1, 3, 5, 7, 9 or 11; or

(E) a nucleic acid which comprises the nucleotide sequence of SEQ ID NO: 1, 3, 5, 7, 9 or 11 except that 1 to 30 nucleotides are substituted, deleted and/or added, and which encodes a polypeptide having the ability to catalyze the reaction of the formula (1) to produce the L-cyclic amino acid.

3. A method of producing an L-cyclic amino acid, the method comprising:

allowing an acyclic α,ω-diamino acid having the following general formula (III):

wherein A is an alkylene chain which has a chain length of from 1 to 4 atoms, which contains or does not contain at least one hetero atom selected from the group consisting of a sulfur atom, an oxygen atom and a nitrogen atom, in the chain or at the end of the chain, and which has or does not have a substituent,

to react with an enzyme capable of converting the amino group at the α-position of the diamino acid to a keto group and producing an α-keto acid, to produce a cyclic amino acid having a double bond at the 1-position and having the following general formula (I):

wherein A is the same as defined above;

and

then producing an L-cyclic amino acid having represented by the following general formula (II):

wherein A is the same as defined above,

from the resulting cyclic amino acid having a double bond at the 1-position by the method according to claim 1 .

4. The method of producing an L-cyclic amino acid according to claim 3 , wherein the enzyme capable of converting the amino group at the α-position of the diamino acid to a keto group and producing an α-keto acid is one or more enzymes selected from the group consisting of a D-amino acid oxidase, an L-amino acid oxidase, a D-amino acid dehydrogenase, an L-amino acid dehydrogenase, a D-amino acid aminotransferase and an L-amino acid aminotransferase.

5. The method of producing an L-cyclic amino acid according to claim 1 , wherein the cyclic amino acid having a double bond at the 1-position and having the general formula (I) is Δ 1 -piperidine-2-carboxylic acid, and the L-cyclic amino acid having the general formula (II) is L-pipecolic acid.

6. The method of producing an L-cyclic amino acid according to claim 1 , wherein the substituent is selected from the group consisting of alkyl groups having from 1 to 4 carbon atoms, aryl groups having from 6 to 12 carbon atoms, alkoxy groups having from 1 to 4 carbon atoms, carboxyl group, halogen groups, cyano group, amino group, nitro group and hydroxyl group.

7. The method of producing an L-cyclic amino acid according to claim 3 , wherein the substituent is selected from the group consisting of alkyl groups having from 1 to 4 carbon atoms, aryl groups having from 6 to 12 carbon atoms, alkoxy groups having from 1 to 4 carbon atoms, carboxyl group, halogen groups, cyano group, amino group, nitro group and hydroxyl group.

Assignments (3)
MERGER Recorded Mar 4, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 070394/0796 →
CHANGE OF ADDRESS Recorded Jun 21, 2023
From: API CORPORATION
To: API CORPORATION
Reel/Frame 064103/0580 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2021
From: MIZUTANI, MASAHARU; MIYAKE, RYOMA; KAWABATA, HIROSHI
To: API CORPORATION
Reel/Frame 058120/0138 →
Priority Claims (1)
JP 2019-084234 · Apr 25, 2019 · national
Continuity (1)
Related Publication 20220275410A1 · Sep 1, 2022
References Cited (27)
US 20050038255A1 · Thibaut et al. · 2005 [cited by applicant]
EP 1033405A2 · 2000 [cited by applicant]
EP 2889378A1 · 2015 [cited by applicant]
JP 2005095167A · 2005 [cited by applicant]
JP 4590981B2 · 2010 [cited by applicant]
WO 2002101003A2 · 2002 [cited by applicant]
WO 2015033636A1 · 2015 [cited by applicant]
Office Action with Search Report that issued in corresponding Chinese patent Application No. 202080031314.1 dated Jan. 29, 2024, along with English translation thereof. [cited by applicant]
NAD(P)-binding Rossmann-fold superfamily protein [ [cited by applicant]
Protein SAR Deficient 4 [Morus notabilis] (LOC21397372), mRNA, NCBI Reference Sequence: XP_010105735.1; Feb. 26, 2018. [cited by applicant]
Extended European Search Report issued in corresponding European patent Application No. 20795814.1 dated May 2, 2023. [cited by applicant]
Database UniProt [Online] May 14, 2014, Anonymous: “RecName: Full=Delta(1)-pyrroline-2-carboxylate reductase {ECO:0000256|Google:ProtNLM};”, PX093040564 retrieved from EBI accession No. Uniprot: W9SGT1 Database accessio… [cited by applicant]
Muramatsu et al., “The putative malate/lactate dehydrogenase from [cited by applicant]
Office Action issued in corresponding Japanese Application No. 2019-084234, dated May 9, 2023, along with English thereof. [cited by applicant]
Hartmann et al., “L-lysine metabolism to N-hydroxypipecolic acid: an integral immune-activating pathway in plants”, The Plant Journal, 2018, vol. 96, pp. 5-21. [cited by applicant]
Hartmann et al., “Biochemical Principles and Functional Aspects of Pipecolic Acid Biosynthesis in Plant Immunity”, Plant Physiology, 2017, vol. 174, pp. 124-153. [cited by applicant]
Ding et al., “Characterization of a Pipecolic Acid Biosynthesis Pathway Required for Systemic Acquired Resistance”, The Plant Cell, 2016, vol. 28, pp. 2603-2615. [cited by applicant]
Definition Predicted: Morus Notabilis Protein SAR Deficient 4 (LOC21397372), mRNA, Database GenBank [online] and Accession XM_010107433, 2018, [retrieved on Apr. 28, 2023]URL: https://www.ncbi.nlm.nih.gov/nuccore/135029… [cited by applicant]
NAD(P)-binding Rossmann-fold superfamily protein [ [cited by applicant]
Fernández-García et al. Tetrahedron: Asymmetry, vol. 6, No. 12, 1995, pp. 2905-2906. [cited by applicant]
Fujii et al. Bioscience, Biotechnology, and Biochemistry, vol. 66 (9), 2002, pp. 1981-1984. [cited by applicant]
Costilow et al. The Journal of Biological Chemistry, vol. 246, No. 21, 1971, pp. 6655-6660. [cited by applicant]
Meister et al. Journal of Biological Chemistry, vol. 229, Issue 2, 1957, pp. 789-800. [cited by applicant]
Payton et al. Journal of Bacteriology, vol. 149, No. 3, 1982, pp. 864-871. [cited by applicant]
Database UniProtRB/TrEMBL [online], accession No. W9SGT1, <https://www.uniprot.org/uniprot/>, May 14, 2014 upload, He, N., Zhao, S., Definition: SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:EXC05955.1}, cols.… [cited by applicant]
International Search Report for PCT/JP2020/019517, dated Jun. 30, 2020, along with an English translation thereof. [cited by applicant]
International Preliminary Report on Patentability issued in PCT/JP2020/019517, dated Sep. 28, 2021, along with an English translation thereof. [cited by applicant]